Terms: = Endocrine gland cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Prognosis
58 results:
1. Analysis of chemoresistance characteristics and prognostic relevance of postoperative gemcitabine adjuvant chemotherapy in pancreatic cancer.
Ren J; Wu S; Su T; Ding J; Chen F; Li J; Wang Z; Han L; Wu Z
Cancer Med; 2024 May; 13(9):e7229. PubMed ID: 38698688
[TBL] [Abstract] [Full Text] [Related]
2. An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer.
Zhu K; Ma J; Tian Y; Liu Q; Zhang J
BMC Womens Health; 2024 Jan; 24(1):49. PubMed ID: 38238671
[TBL] [Abstract] [Full Text] [Related]
3. Characterization of the genomic alterations in poorly differentiated thyroid cancer.
Lee Y; Moon S; Seok JY; Lee JH; Nam S; Chung YS
Sci Rep; 2023 Nov; 13(1):19154. PubMed ID: 37932340
[TBL] [Abstract] [Full Text] [Related]
4. Development and validation of a nomogram for predicting the early death of anaplastic thyroid cancer: a SEER population-based study.
Cui H; Wang R; Zhao X; Wang S; Shi X; Sang J
J Cancer Res Clin Oncol; 2023 Nov; 149(17):16001-16013. PubMed ID: 37689588
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic differences in grading and metastatic lymph node pattern in patients with small bowel neuroendocrine tumors.
Reinhard L; Mogl MT; Benz F; Dukaczewska A; Butz F; Dobrindt EM; Tacke F; Pratschke J; Goretzki PE; Jann H
Langenbecks Arch Surg; 2023 Jun; 408(1):237. PubMed ID: 37332044
[TBL] [Abstract] [Full Text] [Related]
6. Deep epigastric lymph nodes implication in patients' recurrence pattern after cytoreductive surgery in ovarian peritoneal metastases.
El Asmar A; Vouche M; Pop F; Polastro L; Chintinne M; Veys I; Donckier V; Liberale G
Eur J Surg Oncol; 2023 Sep; 49(9):106911. PubMed ID: 37149402
[TBL] [Abstract] [Full Text] [Related]
7. Features of mixed medullary thyroid tumors: An NCDB analysis of clinicopathologic characteristics and survival.
Sandilos G; Lou J; Butchy MV; Gaughan JP; Reid L; Spitz FR; Beninato T; Moore MD
Am J Surg; 2023 Jul; 226(1):53-58. PubMed ID: 36775791
[TBL] [Abstract] [Full Text] [Related]
8. Laparoscopic retroperitoneal lymph-node dissection in metastatic nonseminomatous germ-cell tumors.
Nazzani S; Stagni S; Biasoni D; Catanzaro M; Macchi A; Tesone A; Torelli T; Darisi R; Lo Russo V; Colbacchini C; Lanocita R; Cascella T; Claps M; Giannatempo P; Zimatore M; Cattaneo L; Montanari E; Salvioni R; Nicolai N
Eur J Surg Oncol; 2023 Jan; 49(1):257-262. PubMed ID: 36031470
[TBL] [Abstract] [Full Text] [Related]
9. Is There a Role for Surgical Resection of Grade 3 Neuroendocrine Neoplasms?
Borbon LC; Tran CG; Sherman SK; Ear PH; Chandrasekharan C; Bellizzi AM; Dillon JS; O'Dorisio TM; Howe JR
Ann Surg Oncol; 2022 Oct; 29(11):6936-6946. PubMed ID: 35802214
[TBL] [Abstract] [Full Text] [Related]
10. SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine.
Wang ZW; Pan JJ; Hu JF; Zhang JQ; Huang L; Huang Y; Liao CY; Yang C; Chen ZW; Wang YD; Shen BY; Tian YF; Chen S
Cell Rep; 2022 May; 39(6):110813. PubMed ID: 35545048
[TBL] [Abstract] [Full Text] [Related]
11. [Establishment and application of a nomogram model for prognostic risk prediction in patients with epithelial ovarian cancer].
Li Z; Cai XW; Yan P; Zhou D; He MM; Deng L; Wang YZ; Liang ZQ
Zhonghua Fu Chan Ke Za Zhi; 2022 Mar; 57(3):190-197. PubMed ID: 35385956
[No Abstract] [Full Text] [Related]
12. Leptin Protein Expression and Promoter Methylation in Ovarian cancer: A Strong Prognostic Value with Theranostic Promises.
Assidi M; Yahya FM; Al-Zahrani MH; Elkhatib R; Zari A; Elaimi A; Al-Maghrabi J; Dallol A; Buhmeida A; Abu-Elmagd M
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884678
[TBL] [Abstract] [Full Text] [Related]
13. The prognostic value of the lymph node ratio in patients with stage IIIC ovarian cancer treated with preoperative chemotherapy.
Hai J; Feng L; Yang J; Niu X; Jiang H
Ann Palliat Med; 2021 Nov; 10(11):11504-11511. PubMed ID: 34872275
[TBL] [Abstract] [Full Text] [Related]
14. Inflammatory cytokine-regulated tRNA-derived fragment tRF-21 suppresses pancreatic ductal adenocarcinoma progression.
Pan L; Huang X; Liu ZX; Ye Y; Li R; Zhang J; Wu G; Bai R; Zhuang L; Wei L; Li M; Zheng Y; Su J; Deng J; Deng S; Zeng L; Zhang S; Wu C; Che X; Wang C; Chen R; Lin D; Zheng J
J Clin Invest; 2021 Nov; 131(22):. PubMed ID: 34779408
[TBL] [Abstract] [Full Text] [Related]
15. [Correlation of conventional ultrasound features and related factors with BRAFV600E gene mutation in papillary thyroid carcinoma].
Lv Y; He X; Yang F; Guo L; Qi M; Zhang J; Wang H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Oct; 35(10):925-929. PubMed ID: 34628817
[No Abstract] [Full Text] [Related]
16. [Relationships between decreased LAMC3 and poor prognosis in ovarian cancer].
Lei SM; Liu X; Xia LP; Ke Y; Wei LW; Li L; Yin FJ
Zhonghua Fu Chan Ke Za Zhi; 2021 Jul; 56(7):489-497. PubMed ID: 34304441
[No Abstract] [Full Text] [Related]
17. ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bioinformatics analysis.
Islam S; Kitagawa T; Baron B; Abiko Y; Chiba I; Kuramitsu Y
Sci Rep; 2021 May; 11(1):10563. PubMed ID: 34007003
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic implications of body composition change during primary treatment in patients with ovarian cancer: A retrospective study using an artificial intelligence-based volumetric technique.
Kim SI; Yoon S; Kim TM; Cho JY; Chung HH; Song YS
Gynecol Oncol; 2021 Jul; 162(1):72-79. PubMed ID: 33994146
[TBL] [Abstract] [Full Text] [Related]
19. [The role and mechanism of human trophoblastic cell surface antigen 2 in the invasion and metastasis of ovarian cancer].
Liu MB; Shi XF; Liu K; Song WY; Wang L; Wu HY; Wu GY
Zhonghua Zhong Liu Za Zhi; 2021 Mar; 43(3):299-305. PubMed ID: 33752309
[No Abstract] [Full Text] [Related]
20. The Association of Histologically Proven Chronic Lymphocytic Thyroiditis with Clinicopathological Features, Lymph Node Metastasis, and Recurrence Rates of Differentiated Thyroid cancer.
Aydoğan Bİ; Mutlu ABB; Yüksel S; Güllü S; Emral R; Demir Ö; Şahin M; Gedik VT; Çorapçıoğlu D; Sak SD; Erdoğan MF
Endocr Pathol; 2021 Jun; 32(2):280-287. PubMed ID: 33188468
[TBL] [Abstract] [Full Text] [Related]
[Next]
